NCT00169871View on ClinicalTrials.gov

Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

CompletedOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

December 31, 2006

Conditions

Dyslipidemia

Trial Locations (1)

G1V 4G2

Lipid Research Center, CHUL Research Center, Sainte-Foy

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

CHU de Quebec-Universite Laval

OTHER